These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23998773)

  • 21. Promoting abstinence for drug users is about saving money not science.
    Luty J
    BMJ; 2013 Mar; 346():f1481. PubMed ID: 23525865
    [No Abstract]   [Full Text] [Related]  

  • 22. An experimental study of aggressive and neutral interpretative bias in opiate-dependent and opiate-abstinent men.
    Clair J; Martin L; Bond AJ; O'Ryan D; Davis P; Curran HV
    J Psychopharmacol; 2009 Jun; 23(4):428-35. PubMed ID: 18562417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative evaluation of sharing practices of materials at risk for infectious virus contamination by intravenous opiate users seeking treatment--application of the RAB(Risk for AIDS Behavior) self-administered questionnaire].
    Bertorelle V; Auriacombe M; Grabot D; Franques P; Martin C; Daulouede JP; Tignol J
    Encephale; 2000; 26(3):3-7. PubMed ID: 10951900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suboxone misuse along the opiate maintenance treatment pathway.
    Furst RT
    J Addict Dis; 2013; 32(1):53-67. PubMed ID: 23480248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
    Firestone M; Goldman B; Fischer B
    Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
    Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
    AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Future prospects in treatment of drug dependent patients].
    Ladewig D
    Ther Umsch; 1993 Mar; 50(3):199-203. PubMed ID: 8475475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of the Omaha System intervention on the women's health promotion lifestyle profile and quality of life.
    Erci B
    J Adv Nurs; 2012 Apr; 68(4):898-907. PubMed ID: 21790739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The case for implementing the levels of prevention model: Opiate abuse on American college campuses.
    Daniels-Witt Q; Thompson A; Glassman T; Federman S; Bott K
    J Am Coll Health; 2017 Oct; 65(7):518-524. PubMed ID: 28622135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug abuse treatment in the context of correctional surveillance.
    Nurco DN; Hanlon TE; Bateman RW; Kinlock TW
    J Subst Abuse Treat; 1995; 12(1):19-27. PubMed ID: 7752293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concept analysis of adherence in the context of cardiovascular risk reduction.
    Cohen SM
    Nurs Forum; 2009; 44(1):25-36. PubMed ID: 19187051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of clinic-based health promotion education on perceived health status and health promotion behaviors of adolescent and young adult cancer survivors.
    Smith AB; Bashore L
    J Pediatr Oncol Nurs; 2006; 23(6):326-34. PubMed ID: 17035623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.
    de Wet C; Reed L; Glasper A; Moran P; Bearn J; Gossop M
    Drug Alcohol Depend; 2004 Oct; 76(1):31-5. PubMed ID: 15380286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H; Ruschak M; Silberbauer C
    Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
    Grella CE; Hser YI; Huang YC
    Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoting health in i.v. drug users.
    George S
    Nurs Times; 1999 Jun 30-Jul 6; 95(26):45-7. PubMed ID: 10504963
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auricular acupuncture as an adjunct to opiate detoxification treatment: effects on withdrawal symptoms.
    Bearn J; Swami A; Stewart D; Atnas C; Giotto L; Gossop M
    J Subst Abuse Treat; 2009 Apr; 36(3):345-9. PubMed ID: 19004596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability and construct validity of the Health-Promoting Lifestyle Profile II in an adult Turkish population.
    Pinar R; Celik R; Bahcecik N
    Nurs Res; 2009; 58(3):184-93. PubMed ID: 19448522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.